Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

Affiliations

• ¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
• ² Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
• ³ University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain.
• ⁴ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, The Netherlands.
• ⁵ Leeds Cancer Centre and University of Leeds, United Kingdom.
• ⁶ Department of Hematology, University Hospital Leuven, Belgium.
• ⁷ Faculty of Medicine, University Hospital Ostrava, Czech Republic.
• ⁸ Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway.
• ⁹ KG Jebsen Center for B Cell Malignancies, University of Oslo, Norway.
• ¹⁰ Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
• ¹¹ University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
• ¹² Hôpital Claude Huriez, Lille University Hospital, Lille, France.
• ¹³ Department of Internal Medicine II, University Hospital Wurzburg, Germany.
• ¹⁴ Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Italy.
• ¹⁵ Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.
• ¹⁶ Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
• ¹⁷ Department of Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland.